In Vitro Activity of SYK and BCR-ABL Inhibitors in Aggressive Lymphomas.Francesco Bertoni, F Cavalli, Emanuele Zucca et al.|Blood|2006Cited by 1
Inhibition of the B Cell Associated Tyrosine Kinase SYK as a Potential Therapeutic Target in Aggressive Lymphomas.Francesco Bertoni, Franco Cavalli, Andrea Rinaldi et al.|Blood|2005Cited by 0